GILD - Gilead Sciences Inc

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Stockaholic, Mar 31, 2016.

  1. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    I put up 2 charts last few days. This stock is headed much higher. Don’t listen to the loser "I think we're headed for the $50's crowd"
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    You could at least copy and paste StockTwits comments that don't make you look like a liar on here to people who aren't aware you're copy pasting. No charts from you.
     
  3. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    Zack whose success rate is 1.12% has downgrade this share to sell, that is why it is down. Fyi: zack was bullish when it's 90. I honestly hate this stock, because this one is only down in my portfolio, but still at this point there is more upside then downside
     
  4. Russell

    Russell New Member

    Joined:
    Apr 5, 2017
    Messages:
    2
    Likes Received:
    0
    I'm very long on GILD and agree it is way undervalued. Future EPS puts its value well into $100+ range. Financials are good, sentiment is bad. GILD is currently one of my top 3 picks at wayundervalued.com

    Holding GILD and being patient could really pay off in the long term. Enjoy the dividend in the meantime. When sentiment changes, there's lots of upside here..
     
    #24 Russell, Apr 5, 2017
    Last edited: Apr 6, 2017
  5. EcoWOLFrb

    EcoWOLFrb New Member

    Joined:
    Jul 6, 2016
    Messages:
    23
    Likes Received:
    11
    Looks like maybe breaking the downward trend? They have cash on hand, value play. What do you guys think?
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Day 3 of the big move!
     
  7. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    702
    Likes Received:
    63
    HIV fight advances with new drug cocktails, fresh vaccine hopes
     
  8. Stockaholic

    Stockaholic Content Manager

    Joined:
    Mar 29, 2016
    Messages:
    13,767
    Likes Received:
    7,050
    ER after the close today.

    Here are the consensus & whisper #'s:

    [​IMG]
     
  9. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    34
    Gilead stock looks slightly undervalued at this point because the market is undervaluing Gilead’s HIV and oncology portfolios. The company also shows significant potential in the immunology/NASH area.

    Biktarvy revenues were only $35 million this past quarter. However, this could easily become Gilead’s largest HIV product, hitting a $5 billion mark.
     
  10. KyleLennon

    KyleLennon Member

    Joined:
    Mar 25, 2018
    Messages:
    248
    Likes Received:
    34
    Gilead's tenofovir molecule formed the heart of the firm's $14 billion HIV franchise. Combo pills offer patients convenience and affordability, as they are less likely to miss doses and develop drug resistance, and they only need to make one copayment.
     
  11. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    I haven't followed this stock nearly close enough, but with Remdesivir or whatever it's called, this pullback looks like a decent opportunity to hop in. Might take a chance around $76ish (current 50MA). I'll have to pay closer attention to Covid treatment/vaccine talk though if I hop in to this one.

    upload_2020-5-6_10-33-12.png
     
  12. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    1,588
    Likes Received:
    1,224
     
  13. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    1,588
    Likes Received:
    1,224
    Clinical tests being done as we speak. News everywhere. Don't let a good crisis go to waste.
     
  14. A55

    A55 Well-Known Member

    Joined:
    Jun 28, 2020
    Messages:
    1,033
    Likes Received:
    240
    Gilead is a good company and the stock pays a dividend. Don't look for massive growth. It's not going over $100 anytime soon.
     
  15. emmett kelly

    emmett kelly Well-Known Member

    Joined:
    Dec 21, 2017
    Messages:
    1,588
    Likes Received:
    1,224
    How about $90 on some good clinical trial results? What say you?
     
  16. A55

    A55 Well-Known Member

    Joined:
    Jun 28, 2020
    Messages:
    1,033
    Likes Received:
    240
    Gilead is already making money with HIV treatments. It looks like they lowballed Remdesivir pricing on purpose. $90 is on the horizon for long term investments. Conservatively in 5 years. By then, you should also dividend increases.

    You never know what the future holds. If a vaccine materializes, look for joint marketing and distribution, a merger, or a spin-off into a corona virus focused company. 1stop shopping for hospitals. 1vendor with all corona related supplies.
     
    T0rm3nted likes this.
  17. A55

    A55 Well-Known Member

    Joined:
    Jun 28, 2020
    Messages:
    1,033
    Likes Received:
    240
  18. A55

    A55 Well-Known Member

    Joined:
    Jun 28, 2020
    Messages:
    1,033
    Likes Received:
    240
  19. A55

    A55 Well-Known Member

    Joined:
    Jun 28, 2020
    Messages:
    1,033
    Likes Received:
    240
    Those bookshelves are full of self help books Screenshot_2020-06-30-15-07-02.png Screenshot_2020-06-30-15-13-08.png
     
  20. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    4,319
    Likes Received:
    3,375
    That argument from the WSJ about Remdesivir, didn't work for Sovaldi.
    People had the option of paying $1000/pill for Sovaldi (I think it was 49 pills in 49 days), or not. Of course if you didn't take Sovaldi you risked losing a limb due to liver disease or developing liver cancer, and dying in pain. $1000 seems like a small price to pay to avoid those outcomes. But people got incensed anyway. Because, thanks to the Geneva convention for drug prices, Gilead had to provide low-cost pills to 3rd world countries so poor peoples could get the health benefits too. So while people were paying $1000/pill in the US, you could find similar pills for $5 in India.
     

Share This Page